BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1359803)

  • 1. A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia.
    Booth MG; Marsh B; Bryden FM; Robertson EN; Baird WL
    Anaesthesia; 1992 Oct; 47(10):832-4. PubMed ID: 1359803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
    Kim DW; Joshi GP; White PF; Johnson ER
    Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of rocuronium and vecuronium: the pharmacodynamic, cardiovascular and intra-ocular effects.
    Robertson EN; Hull JM; Verbeek AM; Booij LH
    Eur J Anaesthesiol Suppl; 1994; 9():116-21. PubMed ID: 7925202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia.
    McCoy EP; Mirakhur RK; Maddineni VR; Wierda JM; Proost JH
    Br J Anaesth; 1996 Jan; 76(1):29-33. PubMed ID: 8672375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of age on onset and recovery from atracurium, rocuronium and vecuronium blockade].
    de Almeida MC; Latorre F; Gervais HW; Kleeman PP
    Anaesthesist; 1996 Oct; 45(10):903-6. PubMed ID: 8992904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of the differences in the time to onset of action between rocuronium and vecuronium.
    Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Salmerón J
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):125-30. PubMed ID: 16445711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular effects of rocuronium in children during halothane anaesthesia.
    Vuksanaj D; Skjonsby B; Dunbar BS
    Paediatr Anaesth; 1996; 6(4):277-81. PubMed ID: 8827743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
    Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
    Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of rocuronium bromide in hepatic cirrhosis.
    Hunter JM
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():39-41. PubMed ID: 8557004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of the aminosteroidal non-depolarizing neuromuscular blocking agents rocuronium and vecuronium in plasma with liquid chromatography-tandem mass spectroscopy.
    Gutteck-Amsler U; Rentsch KM
    Clin Chem; 2000 Sep; 46(9):1413-4. PubMed ID: 10973876
    [No Abstract]   [Full Text] [Related]  

  • 13. Onset and recovery of rocuronium (Org 9426) and vecuronium under enflurane anaesthesia.
    Mayer M; Doenicke A; Hofmann A; Peter K
    Br J Anaesth; 1992 Nov; 69(5):511-2. PubMed ID: 1361356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
    Mosing M; Auer U; West E; Jones RS; Hunter JM
    Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming studies with rocuronium and vecuronium.
    Redai I; Feldman SA
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():11-3. PubMed ID: 8556997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priming rapacuronium: a comparison with rocuronium and mivacurium.
    Steinberg D
    Acta Cient Venez; 2003; 54(2):115-20. PubMed ID: 14976782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The haemodynamic effects of rocuronium and vecuronium are different under balanced anaesthesia.
    Stevens JB; Hecker RB; Talbot JC; Walker SC
    Acta Anaesthesiol Scand; 1997 Apr; 41(4):502-5. PubMed ID: 9150779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of cimetidine on the pharmacodynamics of rocuronium].
    Latorre F; de Almeida MC; Stanek A; Weiler N; Kleemann PP
    Anaesthesist; 1996 Oct; 45(10):900-2. PubMed ID: 8992903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The time-course of action and recovery of rocuronium 0.3 mg x kg(-1) in infants and children during halothane anaesthesia measured with acceleromyography.
    Driessen JJ; Robertson EN; Van Egmond J; Booij LH
    Paediatr Anaesth; 2000; 10(5):493-7. PubMed ID: 11012952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics and pharmacokinetics of rocuronium following continuous infusion in patients during intravenous anaesthesia.
    Sparr HJ; Khuenl-Brady KS; Eriksson LI
    Eur J Anaesthesiol Suppl; 1994; 9():63-5. PubMed ID: 7925211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.